PSPA is delighted to be bringing together the international PSP & CBD research community in 2018.
The first truly international research conference on these two devastating neurodegenerative diseases will take place on 25th and 26th October 2018 at the Royal College of Physicians, London.
Working with colleagues at CurePSP, our USA equivalent, we have put together an exciting programme, with around 20 speakers from Europe and North America. All leaders in tauopathy research, they will be sharing latest developments from their various fields, including neuropathology, biomarkers & imaging, genetics and clinical studies. We will also be joined by representatives from the pharmaceutical industry, where PSP is now receiving considerable attention as a testbed for tau-targeting therapies.
We are pleased that the event is also being supported by the PSP Society of Germany and CBD Solutions from Sweden. PSPA is keen to facilitate greater collaboration amongst international patient associations in the future.
“Conferences like this provide the perfect environment for establishing new collaborations and generating new directions for studies” says Andrew Symons, PSPA’s Chief Executive. “We are delighted to be working alongside CurePSP to lead the organisation of this event.”
You can view the programme at: www.eventbrite.com/e/the-first-international-symposium-on-psp-cbd-registration-37916614615?aff=eac2
